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Introduction
• Over 50% of all pregnancies in the state of Vermont are unintended.
• Long-acting reversible contraceptives (LARCs) are the most effective form, yet
the least utilized.
•

Women overwhelmingly choose LARCs when
• educated on their efficacy
•

cost and convenience are equal to other forms.

Available knowledge
• NPs and other providers in primary care are qualified to place IUDs and Nexplanon
• PCPs must offer onsite LARCs to increase uptake
• Barriers cited by PCPs: cost, perceived lack of patient interest, lack of provider confidence
• Current process: patient visits PCP --> PCP refers to gynecology --> 2-3 gyn visits
• Services and procedures at SHS are paid for through a per-student health fee; insurances
are not billed

Rationale
Assumptions:
1.Increased access to effective contraception will
decrease unintended pregnancy
2.Onsite LARC placement will increase uptake

Purpose & Aims
Specific aim: Collect and analyze
available data to create plan for
SHS to implement onsite LARC
insertion.
Overarching purpose: Increase
access to the effective
contraceptive method of choice

Ethical Considerations
• IRB exempt as non-research
• Privacy of patients protected:
• SHS staff performed chart queries
• Removed names and other identifiers before
sending raw data
• Same day goals

Context
• University of Vermont Student Health Services
• Outpatient clinic on campus
• Providers include physicians and nurse practitioners
• Most providers lack recent experience placing LARCs
• Majority of patients are under 30
• Current process: patient visits PCP --> PCP refers to gynecology --> 2-3 gyn visits
• Services and procedures at SHS are paid for through a per-student health fee; insurances
are not billed

Teamwork and Partnerships
• Team:
• Providers at SHS
• Abigail Maynard, FNP
• Medical director
• Administrative coordinator

Planning &
Implementation

Patients Seen for Start or Continuation of Reversible
Contraception over 12 months

Chart review
Measures, over past 12
months:
•Referrals to gyne for
IUD placement
•ICD-10 codes for
contraceptive method

91
37%
115
47%

OCP
Depo-provera
IUD (offsite
referral)

39
16%

Determining logistics of supply, payment &
reimbursement
• Identified barriers
• Cost of stocking devices that might not be used
• SHS does not bill insurance/ for specific procedures
• Perceptions
• Scope of practice
• Patient interest
• Scheduling

Solution for hormonal and copper IUDs
Patient

à

SHS

SHS à
Sends patient’s insurance info to specialty pharmacy
Specialty pharmacy ships device à Device at SHS in 1-7 days
à Patient can return to SHS for placement as early as day of delivery
Total time from initial visit to placement: 1 day to 2 weeks with average of 1
week

Nexplanon
• Medical benefit vs pharmacy benefit
• TheraCom or CuraScript
• Same or next day
• Pharmacy benefit
• Cigna or CVS specialty pharmacies
• Total time from first appointment to placement
• Medical benefit: 1 day to 1 week
• Pharmacy benefit: 1 day to 2 weeks

Discussion

Key findings
1. Benefits of onsite LARC placement outweigh perceived and actual costs.
2. The process to offer onsite LARC placement at SHS will be minimally disruptive to
the clinic because of current insurance legislation, supplier initiative, and the SHS
payment structure.

Associations & Findings
• Staff and provider engagement!
• Insurance law and policy
• Discrepancy: Provider scope of practice
vs initial comfort
• Training and practice
• Cost of intervention

Interpretation
Impact. Increased access to LARCs. Partnerships strengthened.
Comparison of results. Consistent with other studies demonstrating need for LARCs. Part of
slow trend towards placing LARCs at primary care practices, particularly in student health.
Anticipated vs observed outcomes. Launching proposed intervention this academic year,
which is earlier than expected. Provider and staff engagement accelerated
implementation.
Costs and trade-offs. Minimal financial burden to clinic or patients. Disruptions to schedule
and space outweighed by benefits. Same-day, onsite placement ideal but too disruptive
and potentially costly at present.

Limitations
1. Generalizability
Unique cost/billing structure
Demographics
2. Evaluation
Wait 12 months post-implementation to assess effectiveness of practice
change

Sustainability
Next steps
Launching this academic year!
Direct distribution?
Same-day placement?
Potential for spread to other contexts
Future DNP projects?
Specialty pharmacies as solution for
practices
Implications for practice

Conclusions & Next Steps
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